老年心脏病学杂志（英文版）2023，Vol.20Issue(10)：737-747,11.DOI:10.26599/1671-5411.2023.10.002
Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients
Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients
Han-Yang LIANG 1Dong LIU 1Hao WANG 1Zheng-Qing BA 1Ying XIAO 1Yi-Lu LIU 1Yong WANG 2Jian-Song YUAN2
作者信息
- 1. State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,National Center for Cardiovascular Disease,Chi-nese Academy of Medical Science and Peking Union Medical College,Beijing,China
- 2. State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,National Center for Cardiovascular Disease,Chi-nese Academy of Medical Science and Peking Union Medical College,Beijing,China||Key Laboratory of Pulmonary Vascular Medicine,Fuwai Hospital,National Center for Cardiovascular Disease,Chinese Academy of Medical Science and Peking Union Medical College,Beijing,China
- 折叠
引用本文复制引用
Han-Yang LIANG,Dong LIU,Hao WANG,Zheng-Qing BA,Ying XIAO,Yi-Lu LIU,Yong WANG,Jian-Song YUAN..Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients[J].老年心脏病学杂志（英文版）,2023,20(10):737-747,11.
